Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Jan 8, 2026 · Filed Jan 12, 2026
A board member of Globus Medical sold $202K of Globus Medical shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$202,200
Shares × reported transaction price
1 day after results of Jan 7, 2026, 47 days before results of Feb 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.1% | −2.3% | +5.4% |
| 30 days | −3.3% | −1.8% | −1.5% |
| 90 days | +3.1% | −1.1% | +4.2% |
| 180 days | −11.6% | +8.0% | −19.5% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.